News

e@UBC’s Pharmaceutical Target Product Profile Workshop

Published on Thursday, October 01, 2015

e@ubc_correct-

Have an idea or even some data for a drug development opportunity, but don’t know what to do next?

Register for entrepreneurship@UBC’s Target Product Profile (TPP) development workshop to help facilitate discussions with clinicians, advisors, pharmaceutical partners, and investors. The TPP is a fundamental component of any therapeutic program and forms the basis for developing preclinical and clinical plans.

This workshop is for UBC-affiliated faculty, students and staff who have an idea, or even supporting data, for a therapeutic development program. The workshop will provide an overview of the drug development process from discovery through to post-approval activities, and will give participants the tools to build their own TPP through examples and hands-on activities. Drug development experts and commercialization experts will be on hand to help participants with their TPPs. Space is limited to 12 opportunities, so register now!

The workshop will be run by drug development experts from the industry and academic sectors:

Karen Boodram, B.Sc., MBA

IMG_0092

Karen has over twenty-five years of life sciences industry experience including: Principal of BioManna Consulting; Biotech Analyst for Pacific International Securities; and Director of External Affairs for Novartis Pharmaceuticals. She has also held several senior management positions (including Manager of Health Economics) for Ciba-Geigy Pharmaceuticals spanning both the Canadian and European marketplace. Karen works with biotechnology, pharmaceutical and medical device companies across North America. LinkedIn bio.

Sean Lumb, PhD

Unknown

Sean has fifteen years’ experience in venture creation and IP commercialization, with a focus on drug development start-ups. Sean has led or participated in startup company creation, financing, and management, and has considerable experience with IP protection, commercial agreement drafting, negotiation, and execution, including technology licensing, start-up company documentation, and industry-academic collaborations. LinkedIn bio.

Dana Nohynek, MSc, RAC

FullSizeRender

Dana holds a BSc (Honors) from the University of Waterloo, a MSc from the University of Toronto and a RAC certification granted by the Regulatory Affairs Professionals Society (RAPS). She has over 10 years of industry experience that includes the development of regulatory strategies throughout various phases of clinical investigation, extensive interactions with regulatory authorities, preparation and submission of applications to health agencies in Canada, the United States and Europe.

Dana works predominantly with start-up biotechnology, pharmaceutical and medical device companies as well as for the CIHR-funded Canadian HIV Trials Network as Director for Regulatory Affairs & Quality Assurance. LinkedIn bio.

Evalina Rubinchik, PhD

Evalina has over 20 years of industrial and academic experience in drug development. Evalina held roles of Director/Senior Director of Nonclinical Development before launching a successful consulting practice in 2009, focusing on nonclinical toxicology and pharmacology. Clients include biotechnology companies, national drug development and diagnostic centers in Canada and US. LinkedIn bio.

Event Details:

  • When: Wednesday October 14, 9:00am – 1:00pm
  • Where: Robert H. Lee Alumni building

Register for this workshop here. This workshop is free for all UBC students, alumni, faculty and staff.